Microsoft word - potassium acetate hcmi nov2011.doc

DBL™ Potassium Acetate
Concentrated Injection


Potassium Acetate (poe-TAS-ee-um AS-a-tate)

Consumer Medicine Information


What is in this leaflet

You should not be given DBL™
Potassium Acetate
Concentrated Injection if you
have any of the following
medical conditions:
Ask your doctor if you have
any questions about why this
medicine has been prescribed
If you have any concerns about
Before you are given it
this medicine, ask your doctor
or pharmacist.
Tell your doctor if you have
allergies to any other
Keep this leaflet in a safe place.
Before you are given
medicines, foods,
DBL™ Potassium
preservatives or dyes.
Acetate Concentrated

Tell your doctor if you have or

Injection
have ever had any other health
problems/medical conditions,
What DBL™
When you must not be
including:
Potassium Acetate
given it

• kidney disease
Concentrated

You should not be given DBL™

Injection is used for
Potassium Acetate
Concentrated Injection if you
have an allergy to potassium
acetate.
Tell your doctor if you are
pregnant or intend to become
pregnant or are breast-feeding.
the body; rash, itching or hives on the skin. DBL™ Potassium Acetate Concentrated Injection CMI If you have not told your doctor
Tell any other doctors, dentists
about any of the above, tell
and pharmacists who treat you
them before you are given
that you are being given this
DBL™ Potassium Acetate
If you are given too much
medicine.
Concentrated Injection.
(overdose)
If you become pregnant after
Taking other medicines
being given this medicine, tell
your doctor or pharmacist.
Tell your doctor if you are
taking any other medicines,
including medicines that you
buy without a prescription from
Immediately call your doctor or
Side Effects
your pharmacy, supermarket or
telephone the Poisons
health food shop.
Information Centre (In
Tell your doctor or nurse as
Australia, call 13 11 26; In New
soon as possible if you do not
Zealand, call 0800 764 766) for
feel well while you are being
advice, or go to Accident and
given DBL™ Potassium
Emergency at the nearest
Acetate Concentrated Injection.
hospital, if you think that you
or anyone else may have taken
too much DBL™ Potassium
Acetate Concentrated Injection.
Do this even if there are no
signs of discomfort or
poisoning.
Do not be alarmed by the
listed in the ‘Side Effects’ section, following list of side effects.
You may not experience any of
Tell your doctor immediately if
you notice any of the following:
While you are being
given DBL™
• confusion • muscle weakness Potassium Acetate
Concentrated
How DBL™ Potassium
Injection
Acetate Concentrated
Injection is given
Tell your doctor if you notice
anything that is making you
How it is given
feel unwell.
Things you must do
How much is given
Tell your doctor, nurse or
pharmacist if you have any
concerns before, during or
after administration of
potassium acetate.
medical condition and other factors, such as your weight. DBL™ Potassium Acetate Concentrated Injection CMI After being given
New Zealand Sponsor:
Hospira (NZ) Limited
DBL™ Potassium
Acetate Concentrated
Injection
Storage
temperature stays below 25°C.
Disposal

DBL™ Potassium Acetate
Concentrated Injection will be
disposed of by a nurse or
pharmacist.
Product description
What it looks like

DBL™ Potassium Acetate
Concentrated Injection is a clear,
colourless solution.

Ingredients

Each 5 mL ampoule of DBL™
Potassium Acetate Concentrated
Injection contains 2.45g of
potassium acetate and water for
injection.

DBL™ Potassium Acetate
Concentrated Injection does not
contain gluten, lactose, sucrose,
tartrazine or any other azo dyes.

Supplier / Sponsor
DBL™ Potassium Acetate
Concentrated
Injection is supplied by:

Australian Sponsor:
Hospira Australia Pty Ltd.
ABN 58 097 064 330
Level 3
500 Collins Street
Melbourne VIC 3000
Australia
DBL™ Potassium Acetate Concentrated Injection CMI

Source: http://www.hospira.com.au/english/_docs/DBL/Potassium%20Acetate%20cmi.pdf

Coffee, adora2a, and cyp1a2: the caffeine connection in parkinsons disease

European Journal of Neurology 2011, 18: 756–765Coffee, ADORA2A, and CYP1A2: the caffeine connection inParkinsonÕs diseaseR. A. Popata, S. K. Van Den Eedenb, C. M. Tannerc, F. Kameld, D. M. Umbache, K. Marderf,g,R. Mayeuxf,g, B. Ritzh, G. W. Rossi,j, H. Petrovitchi,j, B. Topola, V. McGuirea, S. Costellok,A. D. Manthripragadah, A. Southwickl, R. M. Myersl,* and L. M. NelsonaaDivision of Epidemi

cannasphere.net

Autism and Medical Marijuana Some families have found marijuana to be nothing short of miraculous. Some of the symptoms it has ameliorated include anxiety--even severe anxiety--aggression, panic disorder, generalized rage, tantrums, property destruction and self-injurious behavior. Diane Sawyer, Good Morning America, interviews a mother who used medical marijuana to balance her autistic son.

Copyright © 2010-2014 Medical Articles